Subtopic Deep Dive
Guillain-Barré Syndrome Pathogenesis
Research Guide
What is Guillain-Barré Syndrome Pathogenesis?
Guillain-Barré Syndrome Pathogenesis studies molecular mimicry between Campylobacter jejuni lipooligosaccharides and gangliosides, triggering anti-ganglioside antibodies that cause axonal and demyelinating variants.
This subtopic examines how C. jejuni Penner's serotype 19 (PEN 19) infection precedes GBS with autoantibodies to GM1 ganglioside in patient sera (Yuki et al., 2012; 1194 citations). Key evidence shows bacterial lipooligosaccharide mimicking GM1 structure (Yuki et al., 1993; 504 citations). Over 10 major papers detail antibody roles in axonal versus demyelinating forms (van den Berg et al., 2014; 1021 citations).
Why It Matters
Understanding GBS pathogenesis enables early detection of C. jejuni infection risks for prevention (Yuki et al., 2004; 492 citations). Anti-glycolipid antibodies link to peripheral neuropathy subtypes, guiding IVIG treatments (Willison, 2002; 710 citations). Insights differentiate axonal AMAN from demyelinating AIDP variants, improving prognosis (van Doorn et al., 2008; 814 citations; Shahrizaila et al., 2021; 598 citations). Post-COVID vaccination cases highlight mimicry triggers (Chen et al., 2021; 490 citations).
Key Research Challenges
Axonal vs Demyelinating Distinction
Differentiating AMAN (axonal) from AIDP (demyelinating) relies on anti-ganglioside antibody specificity, but assays vary in sensitivity (van Doorn et al., 2008). Electrophysiological criteria overlap early in disease (Shahrizaila et al., 2021). Over 800 citations address diagnostic gaps (Yuki et al., 2012).
Molecular Mimicry Proof
Direct evidence linking C. jejuni LOS to GM1 autoantibodies remains correlative despite structural homology (Yuki et al., 1993; Yuki et al., 2004). Animal models show incomplete pathogenicity transfer (Willison, 2002). Recent reviews cite 1000+ papers questioning causality (van den Berg et al., 2014).
Trigger Identification Beyond C. jejuni
Non-Campylobacter triggers like post-COVID vaccines induce similar autoantibodies (Chen et al., 2021). Variant-specific antibody profiles need refinement (Hahn, 1998). Foundational works highlight gaps in multi-trigger models (Yuki and Hartung, 2012).
Essential Papers
Guillain–Barré Syndrome
Nobuhiro Yuki, Hans‐Peter Hartung · 2012 · New England Journal of Medicine · 1.2K citations
Sera from patients with Guillain-Barré syndrome (GBS) following Campylobacter jejuni infection have autoantibody to GM1 ganglioside in the acute phase of the illness. There is a strong association ...
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
Bianca van den Berg, Christa Walgaard, Judith Drenthen et al. · 2014 · Nature Reviews Neurology · 1.0K citations
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
Pieter A. van Doorn, Liselotte Ruts, Bart C. Jacobs · 2008 · The Lancet Neurology · 814 citations
Peripheral neuropathies and anti-glycolipid antibodies
H J Willison · 2002 · Brain · 710 citations
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoverie...
Guillain-Barré syndrome
Nortina Shahrizaila, Helmar C. Lehmann, Satoshi Kuwabara · 2021 · The Lancet · 598 citations
A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.
Nobuhiro Yuki, T. Taki, Fuyuhiko Inagaki et al. · 1993 · The Journal of Experimental Medicine · 504 citations
There is a strong association between Guillain-Barré syndrome (GBS) and Penner's serotype 19 (PEN 19) of Campylobacter jejuni. Sera from patients with GBS after C. jejuni infection have autoantibod...
Carbohydrate mimicry between human ganglioside GM1 and <i>Campylobacter jejuni</i> lipooligosaccharide causes Guillain–Barré syndrome
Nobuhiro Yuki, Keiichiro Susuki, Michiaki Koga et al. · 2004 · Proceedings of the National Academy of Sciences · 492 citations
Molecular mimicry between microbial and self-components is postulated as the mechanism that accounts for the antigen and tissue specificity of immune responses in postinfectious autoimmune diseases...
Reading Guide
Foundational Papers
Start with Yuki et al. (1993; 504 citations) for LOS-GM1 structure discovery, Yuki and Hartung (2012; 1194 citations) for clinical-autoantibody links, and Willison (2002; 710 citations) for anti-glycolipid neuropathy context.
Recent Advances
Study Shahrizaila et al. (2021; 598 citations) for updated variants and Chen et al. (2021; 490 citations) for post-vaccination autoimmunity parallels.
Core Methods
Core techniques: ELISA for anti-GM1 antibodies (Yuki et al., 2004), LOS extraction/mass spec (Yuki et al., 1993), nerve conduction studies (van Doorn et al., 2008).
How PapersFlow Helps You Research Guillain-Barré Syndrome Pathogenesis
Discover & Search
Research Agent uses searchPapers and exaSearch to find GBS pathogenesis papers like Yuki et al. (2012; 1194 citations), then citationGraph reveals connections to Yuki et al. (1993) and van den Berg et al. (2014). findSimilarPapers expands to anti-glycolipid antibody studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract LOS-GM1 mimicry details from Yuki et al. (2004), verifies claims with CoVe against 10+ citing papers, and runs PythonAnalysis for citation trend stats using pandas on OpenAlex data. GRADE grading scores evidence strength for molecular mimicry hypotheses.
Synthesize & Write
Synthesis Agent detects gaps in axonal variant triggers, flags contradictions between C. jejuni exclusivity claims (Yuki et al., 2012 vs. Chen et al., 2021). Writing Agent uses latexEditText, latexSyncCitations for Yuki et al. papers, latexCompile pathogenesis diagrams, and exportMermaid for antibody pathway flowcharts.
Use Cases
"Analyze citation trends of anti-GM1 antibodies in GBS papers from 1990-2020"
Research Agent → searchPapers('anti-GM1 Guillain-Barré') → Analysis Agent → runPythonAnalysis(pandas plot citations) → matplotlib trend graph exported as PNG.
"Write LaTeX review section on C. jejuni LOS mimicry with citations"
Synthesis Agent → gap detection(Yuki 1993,2004) → Writing Agent → latexEditText(draft) → latexSyncCitations(Yuki et al.) → latexCompile(PDF with figure).
"Find code for modeling GBS antibody binding simulations"
Research Agent → paperExtractUrls(GBS pathogenesis models) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(test simulation code).
Automated Workflows
Deep Research workflow scans 50+ GBS papers via searchPapers → citationGraph → structured report on pathogenesis variants with GRADE scores. DeepScan applies 7-step CoVe to verify Yuki et al. (1993) mimicry claims against recent citations. Theorizer generates hypotheses linking post-vaccine autoimmunity to LOS mimicry (Chen et al., 2021).
Frequently Asked Questions
What defines Guillain-Barré Syndrome Pathogenesis?
GBS pathogenesis centers on molecular mimicry where C. jejuni PEN 19 lipooligosaccharide mimics GM1 ganglioside, inducing anti-ganglioside antibodies that target peripheral nerves (Yuki et al., 1993; 504 citations).
What are key methods in GBS pathogenesis research?
Methods include serum autoantibody assays for GM1 reactivity, LOS structural analysis via mass spectrometry, and electrophysiology to distinguish axonal AMAN from demyelinating AIDP (Yuki et al., 2012; van Doorn et al., 2008).
What are the most cited papers?
Top papers are Yuki and Hartung (2012; 1194 citations) on GM1 autoantibodies post-C. jejuni, van den Berg et al. (2014; 1021 citations) on pathogenesis overview, and Willison (2002; 710 citations) on anti-glycolipid roles.
What open problems exist?
Challenges include proving direct causality in mimicry, identifying non-C. jejuni triggers like vaccines, and refining variant-specific diagnostics (Shahrizaila et al., 2021; Chen et al., 2021).
Research Peripheral Neuropathies and Disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Guillain-Barré Syndrome Pathogenesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers